Research, develop and grow in Sydney

Sydney, the Gateway to Australia

New South Wales (NSW) is 5th in the world for biotech capabilities, in the top 10 destinations globally for clinical trials, and home to 55% of Australia’s medtech and biotech companies.

With Australia’s largest population, strongest economy, and innovative life sciences sector, NSW is home to an integrated, world-class health and medical research sector that is solving some of the world’s most complex and burdensome healthcare challenges.

Largest and most diverse population base

New South Wales (NSW) has Australia’s largest population, with 8.2 million residents. The state’s population is among the most culturally and ethnically diverse in the world. With one third of the NSW population born overseas and up to 47% with at least one parent born overseas.

Clinical trials can access the entire NSW public health system with one nationally recognised ethics application.

Gateway into the Asia-Pacific

Sydney is home to more than 600 multinational companies with regional headquarters, and hosts many of Australia’s largest venture capital firms. Sydney’s time zone is global, as it spans from North America late afternoon to Europe early morning and is complementary to Asian financial markets.

Research, develop and grow in Sydney

Sydney, the Gateway to Australia

Largest and most diverse population base

Gateway into the Asia-Pacific

Sponsors

Participants

Contact Us

Express Interest Japanese studies

임상 연구에 관심이 있는 한국 과목